Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome Sells 220,000 Shares of Stock

Microbix Biosystems Inc. (TSE:MBX) Director Cameron Lionel Groome sold 220,000 shares of the company’s stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of C$0.33, for a total value of C$72,776.00.

Microbix Biosystems Stock Performance

MBX opened at C$0.34 on Friday. The company has a market capitalization of C$46.48 million, a price-to-earnings ratio of 8.50 and a beta of 0.37. The company has a debt-to-equity ratio of 22.68, a current ratio of 6.62 and a quick ratio of 5.57. Microbix Biosystems Inc. has a 1-year low of C$0.23 and a 1-year high of C$0.45. The business has a 50 day moving average price of C$0.35 and a two-hundred day moving average price of C$0.34.

About Microbix Biosystems

Microbix Biosystems Inc, a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products.